DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Turtle CJ, Hay KA, Hanafi LA. et al.
Durable molecular remissions in chronic lymphocytic leukemia treated with CD19‐specific chimeric antigen receptor‐modified T cells after failure of ibrutinib.

J Clin Oncol 2017;
35: 3010-3020

Download Bibliographical Data

Access:
Access: